Search
NOVN.VX: Entresto approved and priced high, but penetration may not be maximal
- Amit Roy
- Jul 7, 2015
- 1 min read
Entresto was approved last night for heart failure...
with what appears to be a wide label, and is being set at a high price. However guidance may imply a low penetration, and we discuss the concerns that some cardiologists may have
Comments